...
首页> 外文期刊>Allergy, Asthma & Immunology Research >Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study
【24h】

Diagnostic Models for Atopic Dermatitis Based on Serum Microbial Extracellular Vesicle Metagenomic Analysis: A Pilot Study

机译:基于血清微生物细胞外囊泡囊泡分析的特应性皮炎诊断模型:试验研究

获取原文

摘要

PURPOSE:Associations between a wide variety of diseases and the microbiome have been extensively verified. Recently, there has been a rising interest in the role the microbiome plays in atopic dermatitis (AD). Furthermore, metagenomic analysis of microbe-derived extracellular vesicles (EVs) has revealed the importance and relevance of microbial EVs in human health.METHODS:We compared the diversity and proportion of microbial EVs in the sera of 24 AD patients and 49 healthy controls, and developed a diagnostic model. After separating microbial EVs from serum, we specifically targeted the V3-V4 hypervariable regions of the 16S rDNA gene for amplification and subsequent sequencing.RESULTS:Alpha and beta diversity between controls and AD patients both differed, but only the difference in beta diversity was significant. Proteobacteria, Firmicutes, and Bacteroidetes were the dominant phyla in healthy controls and AD patients, accounting for over 85% of the total serum bacterial EVs. Also, Proteobacteria, Firmicutes, Actinobacteria, Verrucomicrobia, and Cyanobacteria relative abundances were significantly different between the AD and control groups. At the genus level, the proportions of Escherichia-Shigella, Acinetobacter, Pseudomonas, and Enterococcus were drastically altered between the AD and control groups. AD diagnostic models developed using biomarkers selected on the basis of linear discriminant analysis effect size from the class to genus levels all yielded area under the receiver operating characteristic curve, sensitivity, specificity, and accuracy of value 1.00.CONCLUSIONS:In summary, microbial EVs demonstrated the potential in their use as novel biomarkers for AD diagnosis. Therefore, future work should investigate larger case and control groups with cross-sectional or longitudinal clinical data to explore the utility and validity of serum microbiota EV-based AD diagnosis.Copyright ? 2020 The Korean Academy of Asthma, Allergy and Clinical Immunology · The Korean Academy of Pediatric Allergy and Respiratory Disease.
机译:目的:广泛验证各种疾病和微生物组之间的关联。最近,对微生物组在特应性皮炎(广告)中的角色发挥着兴趣的兴趣。此外,微生物源细胞外囊泡(EVS)的偏见分析揭示了人类健康中微生物EV的重要性和相关性。方法:我们比较了24名AD患者血清中微生物EVS的多样性和比例和49例健康对照开发了诊断模型。从血清分离微生物EV后,我们特别靶向16S rDNA基因的V3-V4高变区域进行扩增和随后的测序。对照和AD患者之间的α和β多样性都不同,但只有β多样性的差异很大。植物细菌,压缩和细菌是健康对照和广告患者中的主要植物,占总血清细菌EVS的85%以上。此外,在AD和对照组之间,植物体外菌,压缩,抗菌剂,疣状内病症和蓝藻相对丰富在显着差异。在Genus水平,在AD和对照组之间大大改变了大肠杆菌 - shigella,acineTobacter,假单胞菌和肠球菌的比例。使用基于线性判别分析效果大小选择的生物标志物从类别到Genus水平的基础上选择的BioMarkers开发的AD诊断模型在接收器的接收器中,灵敏度,特异性和准确性为1.00。结论:总之,微生物EVS证明了微生物EV潜在用作广告诊断的新型生物标志物。因此,未来的工作应调查具有横截面或纵向临床数据的更大案例和对照组,以探讨血清微生物群EV的型广告诊断的实用性和有效性吗? 2020韩国哮喘学院,过敏和临床免疫学·韩国儿科过敏和呼吸系统院。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号